(Q41728644)

8 October 2017

title

Dermatomyositis: a dermatology-based case series (English)

1 reference

8 October 2017

0 references

Dawkins MA

1

1 reference

8 October 2017

Jorizzo JL

2

1 reference

8 October 2017

Walker FO

3

1 reference

8 October 2017

Albertson D

4

1 reference

8 October 2017

Sinal SH

5

1 reference

8 October 2017

Hinds A

6

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Journal of the American Academy of Dermatology

8 October 2017

published in

1 reference

8 October 2017

volume

38

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

397-404

1 reference

The red face: dermatomyositis

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

1 reference

7 January 2021

Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Membrane Attack Complex Deposits in Cutaneous Lesions of Dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Polymyositis: its presentation, morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Azathioprine with prednisone for polymyositis. A controlled, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Prednisone and azathioprine for polymyositis: long-term followup.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Polymyositis--treatment and prognosis. A study of 107 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Presentation, treatment, and prognosis of idiopathic inflammatory muscle disease in a rural hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Dermatomyositis and malignancy. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Cutaneous changes of dermatomyositis precede muscle weakness

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Therapeutic options in dermatomyositis/polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Amyopathic dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: dermatomyositis sine myositis?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970496-7

7 January 2021

10.1016/S0190-9622(98)70496-7

Identifiers

DOI

1 reference

8 October 2017

1 reference